Cynosure develops, manufactures and markets aesthetic treatment systems that enable plastic surgeons, dermatologists and other medical practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and benign pigmented lesions, remove multi-colored tattoos, revitalize the skin, reduce fat through laser lipolysis, reduce cellulite, clear nails infected by toe fungus, ablate sweat glands and improve women’s health. The Company also markets radiofrequency (RF) energy-sourced medical devices for precision surgical applications such as facial plastic and general surgery, gynecology, ear, nose, and throat procedures, ophthalmology, oral and maxillofacial surgery, podiatry and proctology. Cynosure’s product portfolio is composed of a broad range of energy sources including Alexandrite, diode, Nd: YAG, picosecond, pulse dye, Q-switched lasers, intense pulsed light and RF technology. Cynosure sells its products globally under the Cynosure, Palomar, ConBio and Ellman brand names through a direct sales force in the United States, Canada, France, Morocco, Germany, Spain, the United Kingdom, Australia, China, Japan and Korea, and through international distributors in approximately 120 other countries.

Webcast ImageWebcast
Q4 2016 Cynosure Inc. Earnings Conference Call (Live)
02/07/17 at 9:00 a.m. ET
Q4 2016 Cynosure Inc. Earnings Conference Call
Tuesday, February 7, 2017 9:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
CYNO (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$43.85
Change (%) Stock is Down 0.15 (0.34%)
Volume299,817
Data as of 01/20/17 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote

News Releases

January 06, 2017
Cynosure to Host Fourth-Quarter 2016 Financial Results Conference Call on February 7
December 05, 2016
Cynosure Recognized Among Deloitte's 2016 Technology Fast 500™
November 29, 2016
Cynosure Receives CFDA Clearance to Market the Icon™ Aesthetic System in China
View All Press Releases

Upcoming Events

DateTitle
02/07/17 9:00 a.m. ET
Q4 2016 Cynosure Inc. Earnings Conference Call
Data provided by Nasdaq. Minimum 15 minutes delayed.